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was first recognized for its innate 
immune actions (Fossiez et al., 1996), 
consistent with its rapid production 
in response to microbial infections. 
For example, IL-17 has been shown 
to play a crucial role in host defense 
against Staphylococcus aureus skin 
infections (Ishigame et al., 2009). This 
is consistent with the observation that 
T cells from subjects with hyper-IgE 
syndrome, which is characterized by 
recurrent and often severe pulmonary 
infections, eczema, staphylococcal 
abscesses, and mucocutaneous can-
didiasis, do not produce IL-17 (Milner 
et al., 2008). Studies in recombinase 
activating gene (RAG)-deficient mice, 
which lack B and T cells, demon-
strated that IL-17a could still be pro-
duced in response to IL-23, suggesting 
that there were non-T-cell sources for 
this cytokine (Uhlig et al., 2006). This 
work was followed by multiple publi-
cations that demonstrated several cell 
types found within skin and mucosal 
surfaces produce IL-17a as part of an 
innate immune response (Cua and 
Tato, 2010). Therefore IL-17a can be 
considered part of both an innate and 
an adaptive immune system.
Immunologic classifications  
of allergic disorders
Allergic disorders affect up to 30% of 
the populations in developed coun-
tries and are caused by aberrant 
immune responses to allergens and 
other environmental stimuli. Current 
thinking has led to the recognition 
of at least two variants referred to as 
“atopic” (or extrinsic) and “nonatopic” 
(or intrinsic), which is probably best 
studied in asthma. Atopic asthmatics 
have more Th2-type airway inflamma-
tion characterized by IL-4-, IL-5-, and 
IL-13-secreting cells that result in tissue 
eosinophilia and increased serum IgE 
levels, whereas nonatopic asthmatics 
are characterized by increased IL-8-
producing cells and tissue neutrophilia 
without elevations of IgE (Amin et al., 
2000). It has been suggested that IL-17a 
expression observed in some asthmat-
ics is responsible for the tissue expres-
sion of CXCL8 and neutrophilia that 
is characteristic of the nonatopic vari-
ant. All individuals with atopic derma-
titis (AD) are characterized by a lack of 
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In this issue, Milovanovic and colleagues present evidence that IL-17a enhances 
Ige production, although the precise mechanism remains unclear. Their ini-
tial finding was that higher numbers of IL-17a-producing CD4+ T cells were 
observed after polyclonal stimulation in a largely airway allergic population. 
These data add to the evidence that atopic disorders such as asthma and, pos-
sibly, atopic dermatitis (AD) may have distinct immunologic phenotypes. The 
hope is that by characterizing the immunologic basis of these common diseases 
we will be able to understand the heterogeneity observed in natural history, 
response to treatments, susceptibility to infections, genetic risk factors, and 
associations with other atopic disorders.
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IL-17 history and function
IL-17-producing T cells were initially 
described in autoimmune models 
(Aggarwal et al., 2003; Cua et al., 
2003; Murphy et al., 2003) and led to 
the characterization of a new T helper 
(Th) subset that extended our repertoire 
beyond Th1, Th2, and Th9. Th17 cells 
are thought to be associated with the 
development of autoimmune diseases, 
response to extracellular pathogens, 
and diseases characterized by chronic 
neutrophilic inflammation. IL-17a, one 
of the most studied Th17 cytokines, 
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peripheral blood mononuclear cells 
(PBMCs) from an atopic donor.
Effects of IL-17 on B cells have been 
described only in the BXD2 recom-
binant inbred mouse strain, which 
spontaneously develops glomerulo-
nephritis and erosive arthritis. These 
mice have been shown to express 
IL-17 and develop spontaneous ger-
minal centers, resulting in increased 
autoimmune antibodies (Hsu et al., 
2008). Germinal centers are sites of 
B- and T-cell interactions that result 
in active B-cell proliferation, somatic 
hypermutations, selection, and dif-
ferentiation into memory B cells and 
plasma cells. In these BXD2 mice, 
IL-17 is thought to play an important 
role in the spontaneous development 
of germinal centers by retaining B cells 
and promoting CD4 T-cell and B-cell 
interactions. Mice lacking the IL-17 
receptor have reduced germinal cen-
ter B-cell development and decreased 
antibody responses (Hsu et al., 2008). 
In this mouse strain, IL-17 affected 
B-cell activity, resulting in increases 
in autoimmune IgM and IgG levels, 
although IgE levels were not assessed. 
It is unclear how to reconcile this 
result with Milovanovic et al. (2010), 
who did not observe reductions in IgG 
and IgM levels with blocking IL-17a 
antibodies. One possible explanation 
is that the allergic donor PBMCs used 
for Milovanovic’s studies had already 
experienced the class-switching effects 
of the Th2 cytokines (IL-4 and -13), 
although this and other possibilities 
will require further study.
Several mechanisms could account 
for IL-17a’s ability to increase IgE 
secretion. For example, IL-17 could 
(i) augment IgE secretion of already 
existing IgE plasma cells, (ii) enhance 
differentiation of IgE-switched B cells 
to IgE-producing plasma cells, or (iii) 
promote class switching of memory B 
cells to IgE plasma cells. In this study, 
Milovanovic et al. provide evidence of 
the third mechanism. PBMC cultures 
stimulated for 10 days with IL-17 or 
anti-CD40 + IL-4 induced memory 
B-cell IgE class switching and differ-
entiation into plasma cells as shown 
by similarly increased expression of 
ε germ line transcription, a first step 
in the commitment of B cells to the 
observed (De Benedetto et al., 2009; 
Hurst et al., 2002; Ong et al., 2002; 
Ott et al., 1994).
Although only about 30% of AD 
subjects experience recurrent S. 
aureus infections, greater than 90% 
are chronically colonized with this 
microbe, which would seem unlike-
ly to occur in the context of IL-17 
expression. Interestingly, Eyerich et 
al. (2009) recently observed that the 
Th2 cytokines (IL-4 and -13) present in 
AD lesions can partially inhibit IL-17-
induced human beta defensin (hBD)-2 
expression from human keratinocytes. 
This finding suggests that the balance 
of Th17 and Th2 cytokines may deter-
mine the quality of an innate immune 
response to extracellular pathogens. 
Importantly, Milovanovic and col-
leagues (2010) observed a significant-
ly increased percentage of IL-17a+-
activated CD4+ cells in only 6 of the 23 
allergic donors. All 6 were asthmatics 
and presumably did not have AD. In 
contrast to the antagonism observed 
between IL-17a and Th2 cytokines in 
epidermal innate immune responsive-
ness, the authors observed synergy 
between these two cytokine profiles 
with regard to IgE production. In sum-
mary, their findings support and extend 
the growing literature demonstrating 
that IL-17a expression may define a 
unique allergic phenotype, but deter-
mining the relevance of these findings 
to immune responses in AD skin will 
require further study.
IL-17a promotes Ige production
Milovanovic and colleagues’ study 
presents provocative data suggesting 
that IL-17a enhances IgE production. In 
a small subset of allergic patients com-
pared with normal controls, they show 
higher numbers of IL-17a-producing 
CD4 T cells (Th17) after polyclonal 
activation of whole blood. After deple-
tion of the Th17 cells in vitro from the 
allergic patients, IgE levels decrease. 
Furthermore, repleting IL-17a in the 
depleted cultures reversed the reduc-
tion in IgE. As an important control 
for their methodology they show that 
depletion of IFN-γ-secreting cells did 
not affect IgE production. Furthermore, 
blocking IL-17a affected only IgE and 
not IgG, IgM, or IgA production in 
tissue neutrophilia, whereas those with 
nonatopic AD have slightly reduced tis-
sue expression of IL-5 and IL-13 and 
normal IgE values (Novak and Bieber, 
2003). Although the role of Th2 cells in 
allergic diseases is firmly established, it 
is now clear that CD4+ cells are much 
more heterogeneous than originally 
thought, reflecting previously unsus-
pected degrees of plasticity in Th cell 
differentiation (O’Shea and Paul, 2010). 
A current challenge is to understand 
the role of other Th cell subsets and 
cytokines in allergic diseases, and it is 
intriguing to speculate that expansion 
of different Th cell lineages may result 
in different disease phenotypes.
IL-17a expression in atopic disorders
In this issue, Milovanovic et al. (2010)
report that IL-17a-producing T cells are 
expanded in the peripheral blood of 
allergic human subjects. Although sev-
eral IL-17 family members have been 
implicated in mouse models of asth-
ma and AD, only a few groups have 
found enhanced expression of IL-17a 
in humans with asthma (Hashimoto 
et al., 2005; Molet et al., 2001; Song 
et al., 2008) or AD (Koga et al., 2008; 
Toda et al., 2003). In fact, some groups 
have noted the lack of IL-17a and the 
Th17 differentiation cytokine, IL-23, 
in the skin of AD subjects (Guttman-
Yassky et al., 2008; L. Beck, unpub-
lished data), possibly explaining their 
propensity for skin infections. It has 
been suggested that IL-17a expression 
observed in some asthmatics is respon-
sible for tissue expression of CXCL8 
and neutrophilia that is characteristic 
of the nonatopic variant. In AD the 
characteristic downstream biological 
actions of IL-17a such as neutrophil 
recruitment, epidermal antimicrobial 
peptide production, and enhanced 
tight junction integrity are clearly not 
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production.
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Increased activation-induced cytidine 
deamiase (AID) expression in these 
cultures also suggests the possibility 
that IL-17a could promote class switch 
recombination and somatic muta-
tion, but further studies are needed 
to determine the precise molecular 
mechanisms involved. Another pecu-
liarity of their results was that IL-17a 
did not increase IgE secretion in dose-
escalation fashion; instead, it had an 
optimal concentration at 10 ng/ml, 
and the clinical relevance of such a 
high dose in tissue sites and/or sec-
ondary lymphoid organs will need to 
be addressed.
In summary, this work highlights the 
association of IL-17a and increased IgE 
secretion in human PBMCs. Whether 
the IL-17a-producing cells alone can 
increase IgE levels or whether these 
cells require IL-4 secretion simultane-
ously needs further study. Interestingly, a 
novel population of CD4 memory T cells 
(Th17/Th2) that produce both IL-17 and 
IL-4 has recently been described (Cosmi 
et al., 2010). Albeit extremely rare in 
healthy adults, IL-17 and -4-coproduc-
ing CD4 T cells were increased in the 
circulation of patients with severe asth-
ma, which could explain the relation-
ship between Th17 cells and increased 
IgE levels observed in this study. Perhaps 
this Th17/Th2 subset may identify a new 
phenotype with both neutrophilic infil-
trates and increased IgE that lies some-
where between atopic and nonatopic 
asthma phenotypes. Further research 
investigating the expression and regu-
lation of IL-17a and Th17 cytokines 
in general in humans with AD should 
be worthwhile. It will be important in 
future studies to consider the contribu-
tion of both the innate and the adaptive 
immune systems to IL-17a production 
and to determine where and how this 
interesting cytokine affects B-cell acti-
vation and antibody production.
